Location History:
- Orpington, GB (2013 - 2018)
- Stevenage, GB (2018 - 2022)
Company Filing History:
Years Active: 2013-2022
Title: Innovator Marina Tarunina: Pioneering Advances in Cell Production
Marina Tarunina, an accomplished inventor based in Stevenage, GB, has made significant contributions to the field of cellular biology. With a robust portfolio of five patents, she has dedicated her research to groundbreaking methods in cell production and differentiation.
Latest Patents
Among her latest innovations, Marina has developed methods for producing cells of the hematopoietic lineage using hydrogel encapsulation. This technology involves a hydrogel capsule that contains a stem cell core, which has been induced to differentiate into a hematopoietic lineage cell. Additionally, she has made strides in deriving brown adipose tissue cells from adult stem or progenitor cells, specifically targeting cells derived from adult white fat tissue (WAT). These patents reflect her commitment to advancing therapeutic applications in regenerative medicine.
Career Highlights
Marina currently works at Plasticell Limited, a company that specializes in innovative cell technologies. Her role involves driving research forward, focusing on transforming fundamental scientific findings into practical applications. Throughout her career, she has demonstrated a remarkable ability to bridge the gap between research and product development, impacting various fields of medicine.
Collaborations
In her journey, Marina has collaborated with notable researchers, including Yen Choo and Mylvaganam Jeyakumar. These partnerships have fostered an environment of innovation and have led to the successful advancement of her projects in cellular technology.
Conclusion
Marina Tarunina's work exemplifies the spirit of innovation within the scientific community. Her dedication to advancing cell production techniques through her patented inventions underscores her pivotal role in the field. As she continues to push the boundaries of research at Plasticell Limited, the implications of her work hold promise for the future of regenerative medicine and therapeutic advancements.